138 related articles for article (PubMed ID: 29662377)
1. Identification of complexes of gelatinase A and tissue inhibitor of metalloproteinase-2 in human follicular fluid.
Shimokawa KI; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
Reprod Med Biol; 2003 Sep; 2(3):115-119. PubMed ID: 29662377
[No Abstract] [Full Text] [Related]
2. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Ogata Y; Itoh Y; Nagase H
J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
[TBL] [Abstract][Full Text] [Related]
3. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
Lefebvre V; Peeters-Joris C; Vaes G
Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
6. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
9. Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase.
Ratnikov BI; Deryugina EI; Strongin AY
Lab Invest; 2002 Nov; 82(11):1583-90. PubMed ID: 12429818
[TBL] [Abstract][Full Text] [Related]
10. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
11. Complexes of gelatinases and tissue inhibitor of metalloproteinases in human seminal plasma.
Shimokawa K; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
J Androl; 2003; 24(1):73-7. PubMed ID: 12514086
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
14. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
[TBL] [Abstract][Full Text] [Related]
15. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
17. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
Itoh Y; Binner S; Nagase H
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
[TBL] [Abstract][Full Text] [Related]
18. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
19. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
[TBL] [Abstract][Full Text] [Related]
20. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
Becher N; Hein M; Uldbjerg N; Danielsen CC
Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
